Search research articles
Contact Us
Filters
Showing results (471-480 of 556) with videos related to
Page
of 56
Sort By:
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
May 22, 2023
Mitigation of COVID-19 transmission in endoscopic and surgical aerosol-generating procedures: a narrative review of early-pandemic literature
V W S Chan, L Rahman, H H L Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix
A P Kudelka, T Levy, C F Verschraegen, et al.
Physical Review Letters
|
December 12, 2001
Energy dependence of nuclear transparency in C (p,2p) scattering
A Leksanov, J Alster, G Asryan, et al.
Physical Review Letters
|
February 7, 2003
n-p short-range correlations from (p,2p+n) measurements
A Tang, J W Watson, J Aclander, et al.
The Journal of Clinical Investigation
|
April 1, 2021
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects
Haiyan Qiu, Sebum Lee, Yulei Shang, et al.
The Journal of Clinical Investigation
|
February 11, 2014
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects
Haiyan Qiu, Sebum Lee, Yulei Shang, et al.
Neuron
|
June 21, 2016
Activation of HIPK2 Promotes ER Stress-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis
Sebum Lee, Yulei Shang, Stephanie A Redmond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 14, 2016
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy
M Moore, S Gill, T Asmis, et al.
The New England Journal of Medicine
|
May 4, 2017
Teprotumumab for Thyroid-Associated Ophthalmopathy
Terry J Smith, George J Kahaly, Daniel G Ezra, et al.
Nature Communications
|
July 1, 2021
RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site
Katarzyna Z Haza, Heather L Martin, Ajinkya Rao, et al.
Page
of 56
Search research articles
Search
Showing results (471-480 of 556) with videos related to
Sort By:
Page
of 56
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
May 22, 2023
Mitigation of COVID-19 transmission in endoscopic and surgical aerosol-generating procedures: a narrative review of early-pandemic literature
V W S Chan, L Rahman, H H L Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix
A P Kudelka, T Levy, C F Verschraegen, et al.
Physical Review Letters
|
December 12, 2001
Energy dependence of nuclear transparency in C (p,2p) scattering
A Leksanov, J Alster, G Asryan, et al.
Physical Review Letters
|
February 7, 2003
n-p short-range correlations from (p,2p+n) measurements
A Tang, J W Watson, J Aclander, et al.
The Journal of Clinical Investigation
|
April 1, 2021
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects
Haiyan Qiu, Sebum Lee, Yulei Shang, et al.
The Journal of Clinical Investigation
|
February 11, 2014
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects
Haiyan Qiu, Sebum Lee, Yulei Shang, et al.
Neuron
|
June 21, 2016
Activation of HIPK2 Promotes ER Stress-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis
Sebum Lee, Yulei Shang, Stephanie A Redmond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 14, 2016
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy
M Moore, S Gill, T Asmis, et al.
The New England Journal of Medicine
|
May 4, 2017
Teprotumumab for Thyroid-Associated Ophthalmopathy
Terry J Smith, George J Kahaly, Daniel G Ezra, et al.
Nature Communications
|
July 1, 2021
RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site
Katarzyna Z Haza, Heather L Martin, Ajinkya Rao, et al.
Page
of 56